Autopsy report · NCT04771299

Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients

“Research support no longer available.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 3 years 2 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Lakshmi N Yatham

Sponsor type

University, hospital or other

Conditions

Bipolar I Disorder; Cognitive Impairment

Interventions

Cariprazine; Placebo

Participants

1

Sites

1

Countries

Canada

Trials that died the same way

• Muscle, Essential Amino Acids, and eXercise in Heart Failure
  “There is no longer any funding to support the study” (77% match in meaning)
• Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock
  “The research is no longer funded and terminated due to futility” (72% match in meaning)
• DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant
  “Protocol transitioned to standard of care, no funding available to continue support of research work or data analysis” (69% match in meaning)
• Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
  “Funding agency no longer provide support.” (69% match in meaning)
• Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
  “Study team no longer available to support recruitment and enrollment activities.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.